Showing results (11-20 of 135) with videos related to
Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Evaluation of randomized discontinuation designBoris Freidlin, Richard SimonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patientsBoris Freidlin, Richard SimonNature Reviews. Drug Discovery|August 3, 2006
Strategies for optimizing combinations of molecularly targeted anticancer agentsJanet E Dancey, Helen X ChenThe American Journal of Bioethics : AJOB|March 15, 2011
Inefficacy interim monitoring procedures in randomized clinical trials: the need to reportEdward L Korn, Boris FreidlinClinical Trials (London, England)|July 22, 2016
Non-factorial analyses of two-by-two factorial trial designsEdward L Korn, Boris FreidlinBiometrics|October 25, 2016
Reader reaction on estimation of treatment effects in all-comers randomized clinical trials with a predictive markerEdward L Korn, Boris FreidlinJournal of the National Cancer Institute|September 26, 2022
Augmenting randomized clinical trial data with historical control data: Precision medicine applicationsBoris Freidlin, Edward L KornJournal of the National Cancer Institute|July 21, 2021
A Problematic Biomarker Trial DesignBoris Freidlin, Edward L KornStatistics in Medicine|May 23, 2024
Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two-by-two tableEdward L Korn, Boris FreidlinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Outcome--adaptive randomization: is it useful?Edward L Korn, Boris FreidlinPageof 14